A detailed history of Fmr LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Fmr LLC holds 16,722,755 shares of NVCR stock, worth $235 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
16,722,755
Previous 16,487,278 1.43%
Holding current value
$235 Million
Previous $294 Million 1.31%
% of portfolio
0.02%
Previous 0.02%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$15.37 - $19.4 $3.62 Million - $4.57 Million
235,477 Added 1.43%
16,722,755 $298 Million
Q1 2025

May 12, 2025

BUY
$17.82 - $30.19 $4.58 Million - $7.76 Million
257,139 Added 1.58%
16,487,278 $294 Million
Q4 2024

Feb 13, 2025

SELL
$14.54 - $33.41 $27,175 - $62,443
-1,869 Reduced 0.01%
16,230,139 $484 Million
Q3 2024

Nov 13, 2024

BUY
$15.61 - $23.34 $1.41 Million - $2.11 Million
90,422 Added 0.56%
16,232,008 $254 Million
Q2 2024

Aug 13, 2024

BUY
$11.83 - $24.05 $918,220 - $1.87 Million
77,618 Added 0.48%
16,141,586 $277 Million
Q1 2024

May 13, 2024

BUY
$12.42 - $17.29 $1.26 Million - $1.75 Million
101,201 Added 0.63%
16,063,968 $251 Million
Q4 2023

Feb 13, 2024

BUY
$11.13 - $15.78 $35,827 - $50,795
3,219 Added 0.02%
15,962,767 $238 Million
Q3 2023

Nov 13, 2023

BUY
$16.15 - $42.35 $476,828 - $1.25 Million
29,525 Added 0.19%
15,959,548 $258 Million
Q2 2023

Aug 11, 2023

BUY
$40.29 - $82.51 $5.03 Million - $10.3 Million
124,806 Added 0.79%
15,930,023 $661 Million
Q1 2023

May 11, 2023

BUY
$56.44 - $118.81 $3.87 Million - $8.14 Million
68,538 Added 0.44%
15,805,217 $951 Million
Q4 2022

Feb 13, 2023

BUY
$63.98 - $85.37 $19 Million - $25.3 Million
296,571 Added 1.92%
15,736,679 $1.15 Billion
Q3 2022

Nov 10, 2022

BUY
$67.99 - $89.57 $197 Million - $260 Million
2,898,102 Added 23.11%
15,440,108 $1.17 Billion
Q2 2022

Aug 12, 2022

BUY
$56.6 - $89.9 $103 Million - $163 Million
1,812,136 Added 16.89%
12,542,006 $872 Million
Q1 2022

May 13, 2022

BUY
$60.15 - $84.52 $176 Million - $247 Million
2,926,367 Added 37.5%
10,729,870 $889 Million
Q4 2021

Feb 14, 2022

SELL
$75.08 - $121.99 $35.4 Million - $57.5 Million
-471,384 Reduced 5.7%
7,803,503 $586 Million
Q3 2021

Nov 15, 2021

SELL
$116.17 - $194.55 $156 Million - $262 Million
-1,344,248 Reduced 13.97%
8,274,887 $961 Million
Q2 2021

Aug 13, 2021

BUY
$130.4 - $225.58 $1.25 Billion - $2.17 Billion
9,619,135 New
9,619,135 $2.13 Billion

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.47B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.